Decreased cAMP response element-mediated transcription - An early event in exon 1 and full-length cell models of Huntington's disease that contributes to polyglutamine pathogenesis

被引:114
|
作者
Sugars, KL [1 ]
Brown, R [1 ]
Cook, LJ [1 ]
Swartz, J [1 ]
Rubinsztein, DC [1 ]
机构
[1] Addenbrookes Hosp, Dept Med Genet, Cambridge Inst Med Res, Wellcome Trust, Cambridge CB2 2XY, England
关键词
D O I
10.1074/jbc.M310226200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Huntington's disease (HD) is one of nine neurodegenerative diseases caused by an expanded polyglutamine (polyQ) tract within the disease protein. To characterize pathways induced early in HD, we have developed stable inducible PC12 cell lines expressing wild-type or mutant forms of huntingtin exon 1 fragments or the full-length huntingtin protein. Three cAMP response element-binding protein (CREB)-binding protein-dependent transcriptional pathways, regulated by cAMP response element (CRE), retinoic acid response element, and nuclear factor kappaB, show abnormalities in our exon 1 cell model. Of these, the CRE pathway shows the earliest disruption and is significantly down-regulated as early as 12 h following mutant htt transgene induction. This pathway is also the only one of the three that is similarly perturbed in our full-length HD model, where it is also down-regulated at an early time point, compatible with observations in HD brains. Reduced CRE-dependent transcription may contribute to polyQ disease pathogenesis because overexpression of transcriptionally active CREB, but not an inactive form of the protein, is able to protect against polyQ-induced cell death and reduce aggregation.
引用
收藏
页码:4988 / 4999
页数:12
相关论文
共 4 条
  • [1] Characterisation of immune cell function in fragment and full-length Huntington's disease mouse models
    Trager, Ulrike
    Andre, Ralph
    Magnusson-Lind, Anna
    Miller, James R. C.
    Connolly, Colum
    Weiss, Andreas
    Grueninger, Stephan
    Silajdzic, Edina
    Smith, Donna L.
    Leavitt, Blair R.
    Bates, Gillian P.
    Bjoerkqvist, Maria
    Tabrizi, Sarah J.
    NEUROBIOLOGY OF DISEASE, 2015, 73 : 388 - 398
  • [2] Polyglutamine expansions cause decreased CRE-mediated transcription and early gene expression changes prior to cell death in an inducible cell model of Huntington's disease
    Wyttenbach, A
    Swartz, J
    Kita, H
    Thykjaer, T
    Carmichael, J
    Bradley, J
    Brown, R
    Maxwell, M
    Schapira, A
    Orntoft, TF
    Kato, K
    Rubinsztein, DC
    HUMAN MOLECULAR GENETICS, 2001, 10 (17) : 1829 - 1845
  • [3] In vivo dopamine efflux is decreased in striatum of both fragment (R6/2) and full-length (YAC128) transgenic mouse models of Huntington's disease
    Callahan, Joshua W.
    Abercrombie, Elizabeth D.
    FRONTIERS IN SYSTEMS NEUROSCIENCE, 2011, 5
  • [4] In vitro cell models of Huntington's disease using N-terminal and full-length huntingtin: The relationship between excitotoxicity, mitochondrial dysfunction, and free radicals
    Turner, C
    Jones, L
    Elliston, L
    Cooper, JM
    Schapira, AHV
    MOVEMENT DISORDERS, 2002, 17 : S320 - S321